Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 19287391.
- Also identified by DOI 10.1038/nm.1940 and PMC identifier 2844765.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Amyloid-beta (Abeta) peptides, found in Alzheimer's disease brain, accumulate rapidly after traumatic brain injury (TBI) in both humans and animals. Here we show that blocking either beta- or gamma-secretase, enzymes required for production of Abeta from amyloid precursor protein (APP), can ameliorate motor and cognitive deficits and reduce cell loss after experimental TBI in mice. Thus, APP secretases are promising targets for treatment of TBI.
Medical subject headings
- Amyloid Precursor Protein Secretases
- Brain Injuries